Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLI5100 in Patients With Non-Erosive Reflux Disease
NCT05587322Phase 3Completed
- Sponsor
- Braintree Laboratories
- Start
- Sep 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegoprazan in non-erosive reflux disease (NERD), sponsored by Braintree Laboratories. Started Sep 2022; status: completed.
02
Drugs
tegoprazan
03
Conditions
non-erosive reflux disease (NERD)
Beyond the preview
Go deeper on NCT05587322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05587322.